Natick stem cell therapy company RegenoCell Therapeutics Inc. says it’s negotiating with potential new distributors.
RegenoCell said it expects to finalize one or more distribution deals by the end of the year, increasing patient flow to Regenocell Laboratories Ltd., a subsidiary of the company located in Israel that makes products used to treat congestive heart failure and peripheral artery disease.
The company said it has successfully treated more than 500 patients since 2005, helping people with congestive heart failure to live longer.
